Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
I’ve never seen the pipeline reported anyway like this
Khan says the number of queries being received from potential customers are “greater than they’ve ever been” and the sales pipeline of potential challenge trials being discussed with clients is valued at over £300 million.
£1.25 million
Yes same with me on iweb
When a say a bit, I mean a lot. Without sounding like a ramping idiot the price could easily double again by year end once rumours of imminent very large dividends commence. So yes the turkey will be the biggest Bernard matthews has ever seen this year
So picking up in interviews etc we can expect news on the following in next few months.
1). More flu challenge study contracts
2). Testing of anti viral contract (s) one imminent
3). Another RSV contract
4). Third challenge study testing facility, maybe a fourth which leads on to...
5). ...multiple further covid challenge studies at £10 million a pop each.
That’s the boring stuff over ??
6). Imutex sale- big dividend
7). Wearables sale/ contracts- big divi
Also new exciting stuff
8). Development of 2-3 new challenge study models - funded by big pharma which leads to
9). More new challenge study trials
Anybody think the share price has a bit more to go ??. What have a missed?
Agree lots of demand for shares today at 26.5p
Today’s RNS is a whisker away from confirming revenues for open orphan will be in excess of 100 million GBP in 2021 which brings a market cap of £300 million plus in play. That’s a share price of 45p + not including dividends for imutex and wearables.
My thoughts are it will be related to covid challenge study model and contracts. Or could it be prep biopharm which has gone a bit quiet
Is the interview on 3rd June now available
I see cathal is presenting again tomorrow night. Wonder if news and updated presentation tomorrow in advance of this presentation. The new presentation should read very well
I’m sure cathal mentioned another 4.5 million contract ready to go. Might get that next week as he wouldn’t have wanted to spike share price this week before placing announcement
The beauty about this share is that there could be news on a whole range of different things on Tuesday and any day after. There’s so much expected newsflow in the pipeline and then we also get surprises like quotient antibody testing. Who was expecting that?
Would they consider raising funds to develop coronavirus challenge study to keep it 100% owned by orph or still plan to fund from 3rd party investment
20-30p for your shares plus a stake in the spin off business which could be huge in its own right if the flu v or mosi vaccine come to fruition. What’s not to like about this investment. Exciting times
Bought in for the first time on Friday. Might have picked a gud un by the looks of things
Using gbp to usd exchange rate on both dates looks like only 9 million gbp less today than year end.
Do melody book the £9.99 as revenue then pay the artists, record labels their fees from the revenues. Or do melody only get a fraction of the £9.99 upfront. Anyone know how the financial model works
How's the Chinese pledge to all this new clean energy going to affect hayts business. Very positive would be my guess
LiteBulb has grown from £3m sales in 2011 to over £20m in 2014, through organic growth and acquisition.
CM - I think the fall is purely down to the mass and continual sell off in the small caps market that is currently taking place.,a couple of sells and it is marked down and then this hits stop losses and it falls further. This is then repeated the next day or a day or two later. It's happening everywhere at present. If I'm wrong please let me know as I am looking to buy this stock in the next few weeks.